跳至主要内容
临床试验/NCT07423663
NCT07423663进行中(未招募)1 期

Antimicrobial Effect of Calcium Silicate and Pectin as Intracanal Medications in Necrotic Teeth With Periapical Lesions :A Randomized Controlled Clinical Trial

Suez Canal University1 个研究点 分布在 1 个国家目标入组 63 人开始时间: 2024年9月1日最近更新:
干预措施

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
63
试验地点
1
主要终点
Microbiome Changes

研究概览

简要总结

It is tackling antimicrobial resistance in endodontics, specifically comparing different intracanal medications used in root canal treatment. Given the growing concern over resistant bacterial strains, our study aims to evaluate the effectiveness of various medicaments in eliminating endodontic pathogens while minimising the risk of resistance development. By integrating microbiological analysis and clinical relevance, our research seeks to provide evidence-based recommendations for optimising intracanal disinfection protocols and improving treatment outcomes in endodontic infections.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
21 Years 至 49 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients presenting with a single rooted mandibular premolar tooth with a closed apex and a single patent canal type I in Vertucci's classification (Vertucci et al., 1974).
  • Having a necrotic pulp.
  • A pocket depth measurement of < 3 mm.
  • Teeth with no previous history of endodontic treatment.
  • Teeth with periapical lesions of endodontic origin having a periapical index score of 4 or 5 (Orstavik et al., 1986)
  • Patients who took antibiotics within the period of three months before the study.
  • Non-restorable teeth.
  • Teeth with periodontal pockets deeper than 4mm, with or without concomitant or combined endo-perio communication
  • Multirooted teeth.
  • Previously initiated or treated teeth.
  • Teeth with root canal calcifications or resorption.
  • Teeth with internal/external root resorption or root fracture.
  • Immune-compromised patients or patients with systemic diseases i.e. (diabetes mellitus, human immunodeficiency virus, leukemia, neutropenia, undergoing chemo- or systemic corticosteroid therapy)
  • Teeth with root curvature of more than 15 degrees.
  • Pregnant women
  • Patients with known sensitivity to the medicaments used in this study.

排除标准

  • 未提供

研究组 & 干预措施

Calcium Hydroxide Intracanal medication

Active Comparator

Patients receiving CaOH (Metapaste) intracanal medication

干预措施: Calcium Hydroxide Intracanal medication (Drug)

Calcium silicate based intracanal medication

Experimental

Patients receiving Calcium silicate based (Bio-C Temp) intracanal medication

干预措施: Calcium silicate based intracanal medication (Drug)

Pectin

Experimental

Patients receiving Pectin intracanal medication

干预措施: Pectin (Drug)

结局指标

主要结局

Microbiome Changes

时间窗: From enrollment to the end of treatment at 2 weeks

Compare the changes in the microbial composition of the biofilm inside the infected root canal before and after chemo-mechanical preparation and before and after intracanal medicaments application using DNA next-generation sequencing.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

omar montassir

Assistant Lecturer of Endodontics, Faculty of Dentistry, Suez Canal University

Suez Canal University

研究点 (1)

Loading locations...

相似试验

Antimicrobial Effect of Calcium Silicate and Pectin... | 临床试验